HUT54298A - Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem - Google Patents

Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem Download PDF

Info

Publication number
HUT54298A
HUT54298A HU904053A HU405390A HUT54298A HU T54298 A HUT54298 A HU T54298A HU 904053 A HU904053 A HU 904053A HU 405390 A HU405390 A HU 405390A HU T54298 A HUT54298 A HU T54298A
Authority
HU
Hungary
Prior art keywords
tetrahydro
propenyl
compound
tetramethyl
immunsysthem
Prior art date
Application number
HU904053A
Other languages
German (de)
English (en)
Hungarian (hu)
Other versions
HU904053D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Werner Bollag
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HU904053D0 publication Critical patent/HU904053D0/hu
Publication of HUT54298A publication Critical patent/HUT54298A/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU904053A 1989-07-06 1990-07-02 Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem HUT54298A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH252089 1989-07-06

Publications (2)

Publication Number Publication Date
HU904053D0 HU904053D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-12-28
HUT54298A true HUT54298A (en) 1991-02-28

Family

ID=4235631

Family Applications (1)

Application Number Title Priority Date Filing Date
HU904053A HUT54298A (en) 1989-07-06 1990-07-02 Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem

Country Status (9)

Country Link
EP (1) EP0407788A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0344320A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR910002434A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU5861690A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2017956A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT54298A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE902438A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL94942A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA905125B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202500A (ja) * 1984-03-27 1985-10-12 松下電器産業株式会社 音素認識方法
ES2083891B1 (es) * 1991-04-24 1997-01-16 Univ Valencia Estudi General Procedimiento de obtencion de derivados del 2-(1-propenil) fenol.
KR20010012504A (ko) * 1997-05-14 2001-02-15 아테로제닉스, 인코포레이티드 심장혈관질병 및 염증성질병의 치료용 프로부콜모노에스테르

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
ZW6587A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche Tetrahydro naphthanline derivatives

Also Published As

Publication number Publication date
HU904053D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-12-28
AU5861690A (en) 1991-01-10
EP0407788A3 (en) 1991-05-15
CA2017956A1 (en) 1991-01-06
EP0407788A2 (de) 1991-01-16
KR910002434A (ko) 1991-02-25
IE902438A1 (en) 1991-06-19
ZA905125B (en) 1991-03-27
JPH0344320A (ja) 1991-02-26
IL94942A0 (en) 1991-06-10

Similar Documents

Publication Publication Date Title
US8383150B2 (en) Granulate formulation of pirfenidone and pharmaceutically acceptable excipients
HUE032963T2 (en) (Z) -2-Cyano-3-hydroxy-but-2-enoic acid (4'-trifluoromethylphenyl) amide tablet formulation with improved stability
JPS608000B2 (ja) アミノフエニル誘導体及び該誘導体を含有する生理活性剤
JPH0720966B2 (ja) 製薬学的に活性な化合物を含有する病気治療剤
WO2025167361A1 (zh) 6-((5,6-二苯基-1,2,4-三嗪-3-基)(异丙基)氨基)-n-(甲基磺酰基)己酰胺晶型a及其用途和制备方法
CN105753719B (zh) 一种盐酸曲恩汀化合物
HUT54298A (en) Process for producing pharmaceutical compositions containing p(2-)5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtyl(-propenyl)-phenol active for the immunsysthem
RU2108100C1 (ru) Иммуномодулятор
WO2021177397A1 (ja) L-エルゴチオネイン含有組成物
JPS60120995A (ja) 新規アミノ酸誘導体の製法
JPS6116399B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS63264527A (ja) 抗エイズウイルス剤
JP6085706B1 (ja) 抗トリトリコモナス剤
JPH02250828A (ja) 新規免疫抑制剤
EP3878840A1 (en) Crystalline forms of salts of n1,n12-di (all-trans-retinoyl)spermine, processes for their production, and pharmaceutical compositions thereof
JPS61145118A (ja) 免疫調節剤
WO2025002076A1 (zh) 一种mk2抑制剂在制备预防和/或治疗疾病药物中的应用
US5098933A (en) Pharmaceutically useful Michael addition products of unsaturated aldehydes and ketones and ascorbic acid
US3169908A (en) Therapeutic 3-(alpha, alpha, alpha-trifluoro-m-tolyloxy)-1, 2-propanediol-1-carbamate
RU2002738C1 (ru) Способ получени производных N-гидроксимочевин в виде R- или S-энантиомерных форм или их смеси, или их фармацевтически приемлемых солей с щелочным металлом
JP4945869B2 (ja) 免疫賦活剤
JPH04208271A (ja) インターフェロン産生促進剤
HK1007428A1 (en) (alfa-t-butyl aminomethyl-3,4-dichlorobenzyl) thioacetamide, process for its preparation and its applications
JPH0717506B2 (ja) 免疫グロブリンeに起因する疾患治療剤
JPS58208223A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
DFC9 Refusal of application